BioSpace News Archive

Brooklyn ImmunoTherapeutics, Inc . today announced financial results for the fourth quarter and year ended December 31, 2021.

Anika Therapeutics, Inc. today announced that on April 1, 2022, Anika granted non-statutory stock options covering an aggregate of 10,662 shares of common stock (the “Options”) and restricted stock units (the “RSUs”) covering an aggregate of 5,024 shares of common stock to 3 newly hired non-executive employees.

HRH is Only Hospital in Hudson County with Any SRC Accreditation.

Milestone Pharmaceuticals Inc. today announced that Milestone’s Compensation Committee granted one new employee 65,000 incentive stock options at a per share exercise price of $6.85.

Click Therapeutics, Inc. today announced that it has secured a $15 million term loan from Silicon Valley Bank.

BeiGene, Ltd. announced that the China National Medical Products Administration has granted approval to BeiGene’s anti-PD-1 antibody, tislelizumab, as a treatment for patients with locally advanced or metastatic esophageal squamous cell carcinoma who have disease progression or are intolerant to first-line standard chemotherapy.

Catalent today announced that it will release financial results for the third quarter of fiscal year 2022 ended March 31, 2022, before the market open on Tuesday, May 3, 2022.

Kezar Life Sciences, Inc today announced that the company’s Board of Directors has granted one employee a nonqualified stock option to purchase 100,000 shares of its common stock with an exercise price of $15.44 per share.

Jaguar Health, Inc. announced today that the Company’s New Employee Inducement Award Plan.